반응식
[Cl:1][C:2]1[CH:3]=[C:4]([C:8]2[N:13]=[C:12]([C:14](O)=[O:15])[CH:11]=[CH:10][C:9]=2[N:17]2[CH2:20][C:19]([F:22])([F:21])[CH2:18]2)[CH:5]=[CH:6][CH:7]=1.[CH:23]1([CH2:26][C@H:27]([NH2:34])[C:28]2[N:32]=[C:31]([CH3:33])[O:30][N:29]=2)[CH2:25][CH2:24]1>>[CH:23]1([CH2:26][C@H:27]([NH:34][C:14]([C:12]2[CH:11]=[CH:10][C:9]([N:17]3[CH2:20][C:19]([F:21])([F:22])[CH2:18]3)=[C:8]([C:4]3[CH:5]=[CH:6][CH:7]=[C:2]([Cl:1])[CH:3]=3)[N:13]=2)=[O:15])[C:28]2[N:32]=[C:31]([CH3:33])[O:30][N:29]=2)[CH2:25][CH2:24]1참가 물질
3
반응물 2
생성물 1
실험 절차
The title compound was synthesized in analogy to Example 1, using 6-(3-chloro-phenyl)-5-(3,3-difluoro-azetidin-1-yl)-pyridine-2-carboxylic acid (Example 140 a) and (S)-2-cyclopropyl-1-(5-methyl-[1,2,4]oxadiazol-3-yl)-ethylamine (Example 38 e) as starting materials, MS (EI): m/e=474.1 [M+H]+.
출처 및 근거
- ORD 기록
- ord-e03a8cd7e0fb4bb8acf134b82c74750c
- 출처 데이터셋
- uspto-grants-2016_04
- 특허 번호
- US09321727B2
연결된 노트
불러오는 중…